CRMBQ: R.J. Reynolds Descendant Bets on Bankrupt Crumbs

New Post Public Reply Private Reply Replies (0) Message Board
Ospreyeye
CRMBQ: R.J. Reynolds Descendant Bets on Bankrupt Crumbs Cupcake Chain - By Miles Weiss Jul 18, 2014

http://www.bloomberg.com/news/2014-07-18/r-j-...chain.html

A great-grandson of R.J. Reynolds Tobacco Co.’s founder bought a stake in Crumbs Bake Shop Inc. (CRMUQ), betting that he and other shareholders will receive a piece of the cupcake chain once it emerges from bankruptcy.

W. Noah Reynolds, a former certified public accountant who lives in Winston-Salem, North Carolina, acquired a 6.3 percent stake in Crumbs through the purchase of 800,000 common shares, according to a filing yesterday with the U.S. Securities and Exchange Commission.

Marcus Lemonis, the star of the CNBC reality show “The Profit,” has formed a joint venture with Fischer Enterprises LLC to provide financing and ultimately acquire the assets of Crumbs, a New York-based chain that went public three years ago as cupcake specialty stores peaked in popularity. Reynolds, who now invests in real estate and teaches as an adjunct instructor at the University of North Carolina at Greensboro, said that Lemonis will probably preserve some value for existing shareholders in the reorganized company.

“I am banking on Mr. Lemonis’s reputation,” Reynolds, 41, said in an e-mailed response to questions. “I will either own a few crumbs in the new business or be wiped out.”

Crumbs filed for bankruptcy protection earlier this month, listing assets and debts of as much as $50 million in a Chapter 11 filing in U.S. Bankruptcy Court in Newark, New Jersey. The company, known for supersized cupcakes topping out at 1,090 calories each, shut all of its stores on July 7.


Photographer: JB Reed/Bloomberg
A Crumbs cupcake store in New York.
Case Study

Reynolds, who had been preparing a case study on Crumbs for one of his classes, said he began buying the chain’s stock after CNBC reported on July 10 that Lemonis, the chief executive officer of Camping World, was putting together an acquisition offer and financing. Company shares soared 16-fold to 48 cents that day from a closing price of 3 cents on July 9.

Reynolds said he is one of the 22 living great-grandchildren of Richard Joshua Reynolds, the founder of the tobacco company. Noah’s grandfather was R.J. Reynolds Jr., the first son of Richard Joshua Reynolds, who was born in 1850 and died in 1918.

Reynolds said he spent more than $250,000 to acquire the Crumbs stake, adding that the investment was based in part on his knowledge of Krispy Kreme Doughnuts Inc., which is headquartered in Winston-Salem.

Crumbs “is very similar to Krispy Kreme,” Reynolds said, adding that a member of the doughnut chain’s founding family was his wrestling coach in high school. “We had a sweet confection business that grew too fast and went bust.”

To contact the reporter on this story: Miles Weiss in Washington at mweiss@bloomberg.net

To contact the editors responsible for this story: Nick Turner at nturner7@bloomberg.net; Christian Baumgaertel at cbaumgaertel@bloomberg.net; Andrew Dunn at adunn8@bloomberg.net John Lear

Facebook Twitter Google+ LinkedIn
by TaboolaSponsored ContentFrom The
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cardinal Health Surges with Increased EPS Outlook

Updated Category News Views 111

Cardinal Health's Towering Numbers and Raised Outlook Holy moly, Cardinal Health is strutting out of the gate like they mean business. Their first quarter for fiscal year 2027 showed revenue hitting a hefty $67.5 billion—up 5% from last year. If you're holding NYSE:CAH, you might be grinning ear to ear right now. Cardinal didn’t just squeeze out more revenue; they saw...

Continue Reading
Verismo's SynKIR™-310 Shows Promise in Phase 1 Trials

Updated Category News Views 74

KIR-CAR: A Fresh Take on Cancer Treatment So, Verismo Therapeutics is at it again with their KIR-CAR platform. They're set to present interim data at this year's ASH Annual Meeting. To all those following B-cell non-Hodgkin Lymphoma (B-NHL) treatments, pay attention. SynKIR™-310, a CD19-targeted therapy, is showing some real promise. The science behind this is like...

Continue Reading
Mondego Bio Charges Ahead with Cancer Therapy Trials

Updated Category News Views 78

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Continue Reading
Chris Auffenberg Delivers Ford Blue Advantage Gains

Updated Category News Views 18

Can't Ignore Ford's New Strategy in Pre-Owned Cars The auto industry may feel like a runaway train sometimes, and keeping up with the latest turns can be a headache. But here's something catching my eye: Chris Auffenberg Ford's new move with the Ford Blue Advantage certified pre-owned vehicles. It's not just any run-of-the-mill used car deal—this one's got some beef...

Continue Reading
Reviving Carbide Tools: Resharpening for Cost Control

Updated Category News Views 52

Trading Rust: Resharpening Carbide Cutting Tools Alright, picture this: you've got a toolbox full of worn carbide tools, each looking like they've seen better days. You might toss 'em out and grab some new ones, right? But hold on! Carl Ciesla, a cutting tool vet from Sanborn, NY, is talking all about how resharpening could be your ticket to saving a heap of cash and...

Continue Reading
Norwegian Cruise Line's Black Friday Big Splash

Updated Category News Views 65

Jump Aboard NCL's Black Friday Bargain Ship Grab your life jackets, folks! Norwegian Cruise Line (NCL) is sailing with an irresistible Black Friday offer: 50% off all cruises, complete with their much-lauded Free at Sea package. Yeah, if you've been fence-sitting about taking the plunge into the cruise lifestyle, now might just be the time to buckle up your life vests. A...

Continue Reading
Bioactive Research: Converting Science into Guidance

Updated Category News Views 0

Unlocking the Science of Dietary Bioactives Amidst a world swimming in kale smoothies and exotic teas, ILSI U.S. & Canada gathered the sharpest minds to discuss dietary bioactives, an area once shrugged off but now coming into its own. On October 28, 2026, over 250 folks from government, academia, and industry tuned in, looking to understand how these compounds, found in...

Continue Reading
Aker Solutions Lands Big Role in Qatar Oil Upgrade

Updated Category News Views 88

Qatari Venture Beckons Aker Solutions Well, it's not every day you hear about a decades-old oil field getting a facelift, and yet here we are. Aker Solutions has received a nod of approval with a letter of award from PTSC Mechanical and Construction Limited Company (PTSC M&C). This gig is all about the Maydan Mahzam oil field way off the Qatari coast—a legacy site...

Continue Reading
Utility Returns: Short-Term Savings, Long-Term Costs

Updated Category News Views 64

Crunching the Numbers on Utility Returns There's a buzz in the utility sector, and it's not just the hum of power lines—it’s all about return on equity (ROE). Concentric Energy Advisors just dropped some insights that could have us rethinking how these returns play into customer bills and utilities' financing capabilities. What's the Deal with ROE? Think of ROE like a...

Continue Reading
Qfin Faces Stock Lawsuit: Know Your Investor Rights

Updated Category News Views 82

Qfin in the Legal Hot Seat When you hear about a company's legal wranglings, especially one like Qfin Holdings, Inc., you've got to sit up and take notice. We're not talking about a quick scuffle here; this is a full-blown class action lawsuit with its talons sunk deep into allegations of securities law violations. They're squared off against DJS Law Group, an outfit that...

Continue Reading

Top 5 Most Recently Viewed Articles

M-DAQ Expands Footprint: Eyes Vietnam's Booming Economy

Updated Category News Views 51

Strategic Moves in the ASEAN Financial Arena Now, this one's got some bite to it. M-DAQ Global's foray into Vietnam isn't just another step on the fintech ladder - it's a bold expansion play into one of ASEAN's fastest up-and-comers. Forget the usual corporate fluff; what we're seeing here is a calculated strike to grab a piece of a pie that's only getting bigger. Why...

Continue Reading
IDEAYA Biosciences, Inc. Reports Strong Progress in 2024

Updated Category News Views 194

IDEAYA Biosciences, Inc. Achieves Significant Milestones in Financial Reporting IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a pioneering precision medicine oncology company, recently shared its financial results for the fourth quarter and the full year of 2024. The company is dedicated to the discovery and development of targeted therapeutics, making noteworthy strides...

Continue Reading
5N Plus Inc. Enhances Supply Partnership with First Solar

Updated Category News Views 256

Introduction to the New Supply Agreement 5N Plus Inc. (TSX: VNP), a global leader in specialty semiconductors and performance materials, recently announced a major expansion of its supply agreement with First Solar, Inc. (NASDAQ: FSLR). This partnership is vital in supplying increased volumes of critical materials essential for the production of photovoltaic solar...

Continue Reading
Energy Services of America Shines at Upcoming Investor Conference

Updated Category News Views 162

Highlighting Energy Services of America's Upcoming Investor Conference Energy Services of America (NASDAQ: ESOA) is preparing to make a significant impact at an upcoming investor conference. The event will feature presentations by the company's top executives, providing insights into the organization’s future strategies and objectives. Key Presenters at the Conference...

Continue Reading
Ophthalmic Drugs Market Expected to Hit $67.83 Billion by 2033

Updated Category News Views 51

Overview of the Ophthalmic Drugs Market The ophthalmic drugs market is experiencing impressive growth, largely due to the increasing prevalence of eye diseases and innovative advancements in drug development. In 2023, the market was valued at USD 37.17 billion and is expected to grow at a remarkable CAGR of 6.2% from 2024 to 2033, surpassing USD 67.83 billion. Recent...

Continue Reading